Chartwell Investment Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
O
FAM
Chartwell Investment Partners's EXAS Position: Q1 2018 in Review
Chartwell Investment Partners sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 31,594 shares — an estimated $1.66M sold.
Chartwell Investment Partners first reported a position in EXAS in Q3 2016 and held it in 3 quarters. The position peaked at $3.51M in Q3 2016. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.
- Chartwell Investment Partners reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
- Chartwell Investment Partners sold 31,594 Exact Sciences shares in Q1 2018, an estimated $1.66M.
- Chartwell Investment Partners first reported a position in Exact Sciences in Q3 2016 and held it in 3 quarters.
- Chartwell Investment Partners's Exact Sciences position peaked at $3.51M in Q3 2016.
- 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.
Based on Chartwell Investment Partners's 13F filing for Q1 2018, filed 8 May 2018.